Although the existence of mtNOS has been described in mitochondrial fractions from different organs, recent evidence in rat liver mitochondria has questioned the existence of mtNOS, minimizing the contribution of in situ NO generation within mitochondrial to the formation of peroxynitrite (Venkatakrishnan et al., 2009)
You get medication and basic medical oversight
In the meantime, restricted access creates disparities in treatment availability, limits geographic expansion, and introduces frustration for healthcare providers and patients alike
Regular monitoring appointments with your prescribing clinician are essential to assess treatment response, manage side effects, and ensure Saxenda remains appropriate and safe for your individual circumstances
Your HSA or FSA administrator may require documentation from your healthcare provider confirming the medical necessity of GLP-1 therapy for weight management or metabolic health